| In partnership with |  |
| Congratulations to the Dodgers, what a beat down! | Here's another BEAT-DOWN… | 40 make that 51 straight wins for Jason Bond in the $2,000 Small Account Journey. (*Trading is hard, results not guaranteed and should not be expected to be replicated typically.) | Hurry on in … MEGA SALE ENDS IN: | | | FOCUS LIST🔎 | EFSH - Up over 60% in pre after announces closing of $11.1 million public offering | AVDL - Up over 27% in pre after announcing favorable ruling in Administrative Procedure Act Litigation | TNON - Up over 30% in pre after announcing initial clinical cases successfully completed with company's new Catamaran(R) SE SI Joint Fusion System | | *Sponsored by ESGold | Keep This Gold Stock on your Watchlist 🇨🇦 $ESAU 🇺🇸 $SEKZF | | Gold prices hit an all-time high ESGold stock is up over 50% this month Committed to eco-friendly mining practices
| Read More | Disclaimer: This ad is paid for and disseminated on behalf of ESGold Corp (it is sponsored content). We do not own any securities of ESGold Corp. This ad contains forward-looking statements, which are not historical facts. These statements are based on the current beliefs and expectations of ESGold Corp's management and involve known and unknown risks, uncertainties, and other factors that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," and similar expressions often identify forward-looking statements. This is not financial advice, please do your own DD. See SEDAR+ for more information. |
|
| | HOTLIST🔥 | EFSH - Up over 60% in pre after announces closing of $11.1 million public offering | 1847 Holdings LLC (EFSH) through its subsidiaries, focuses on acquiring and managing a group of small businesses in the United States and internationally. It operates through four segments: Retail and Appliances, Retail and Eyewear, Construction, and Automotive Supplies. | In the after-hours yesterday, the company announced it has closed its previously announced fully marketed public offering of securities for gross proceeds of $11.1 million, prior to deducting placement agent fees and other offering expenses payable by the Company. | The public offering was comprised of 8,809,512 units, at a public offering price of $1.26 per unit. Each unit is comprised of (i) one (1) common share or a pre-funded warrant to purchase one (1) common share at an exercise price of $0.01 per share, (ii) a series A warrant to purchase one (1) common share at an exercise price of $1.90 per share and (iii) a series B warrant to purchase one (1) common share at an exercise price of $2.52 per share. |
Shares of EFSH traded up over 60% in the pre-market in reaction to the news.
| | The $0.65 area acted as resistance in the pre-market and will be an important level to watch. | Above it, targets to the upside are $0.70, $0.75 and then the pre-market high at $0.80. | Below $0.65, targets to the downside are $0.58, $0.5381, $0.45 and a gap fill at $0.3883. | | AVDL -Up over 27% in pre after announcing favorable ruling in Administrative Procedure Act Litigation | Avadel Pharmaceuticals plc (AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. | In the pre-market this morning, the company announced the U.S. District Court for the District of Columbia ruled in favor of the Food and Drug Administration ("FDA") in a suit brought by Jazz Pharmaceuticals Inc. under the Administrative Procedure Act regarding the FDA's approval of LUMRYZTM, the first and only once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in adults with narcolepsy. | With this ruling, the approval of LUMRYZ is upheld based on the FDA's determination that LUMRYZ is clinically superior to Jazz's twice-nightly oxybate products. | "With the Court's decision, LUMRYZ will continue to be available to the narcolepsy community and retain its Orphan Drug Exclusivity," said Greg Divis, Chief Executive Officer at Avadel Pharmaceuticals. "Yesterday's ruling further solidifies LUMRYZ's unique once-at-bedtime dosing schedule as a major contribution to patient care and enables us to continue executing on our commercial launch and expanding LUMRYZ's reach within the narcolepsy community." | Shares of AVDL traded up over 27% in the pre-market in reaction to the news. | | The first target for bulls is the pre-market high at $16.98 | Beyond that, $17.30, $18 and $19 come into play. | Below $16.98, targets to the downside are $16, $15, $14 and $13. | | | | TNON - Up over 30% in pre after announcing initial clinical cases successfully completed with company's new Catamaran(R) SE SI Joint Fusion System | Tenon Medical Inc. (TNON) is a medical device company that engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. | In the after-hours yesterday, the company announced the completion of the initial clinical cases utilizing the Company's new Catamaran SE SI Joint Fixation Device. | The new implant offers a 30% reduction in implant width as compared to the original Catamaran Fixation Device, providing physicians with options for smaller SI joint anatomy or revising previously treated SI joints with failed alternative SI joint implants where space is limited. | Initial user experience with the Catamaran SE is underway with a select group of physician operators who are expected to provide valuable feedback to support a broader Catamaran SE market introduction in the coming months. | Successful procedures utilizing the Catamaran SE have been completed in various centers of excellence throughout the country including in Idaho, Pennsylvania, Minnesota, Arizona, and Utah. | Shares of TNON traded up over 30% in the pre-market in reaction to the news. | | The $4 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $4.20, $4.40, $4.60 and then the pre-market high at $4.74. Beyond that, $5.10, $5.50 and $5.95 come into play. | Below $4, targets to the downside are $3.85, $3.66, $3.50 and then a gap fill at $3.26. | | MARKET NEWS 📰 | | | P.S. Make sure you text "RAGE" to (888) 404-5747 to get all of our latest HOT STOCK ideas! | | Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull | | DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer | FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. | RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. | RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. | RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys' fees, costs and disbursements in addition to any other relief to which it may be entitled. | *Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don't spend any money on these products or services unless you believe they will help you achieve your goals. | WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. |
|
|
|
Tidak ada komentar:
Posting Komentar